[1]
M. Kara, G. Alp, and H. Cinakli, “Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention”, Archives of Rheumatology, vol. 40, no. 3, pp. 279–287, Sep. 2025.